| ²é¿´: 550 | »Ø¸´: 4 | ||
zhangxiaÒø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÖÐÒëÓ¢-ÉúÎï¼¼Êõ
|
|
±¾¿ÎÌ⽫aºÍÐÂÐÍ·Ö×Ó±ê¼Ç¼¼ÊõÏà½áºÏ£¬Ó¦Óò»Í¬¼ÁÁ¿b¶Ôc½øÐзøÕÕÓձ䣬ÀûÓÃd¼¼ÊõºÍe£¬¶Ôµ÷¿ØÆäÓÐЧ³É·Öº¬Á¿µÄ»ùÒòÀàÐͽøÐзÖÎö£¬É¸Ñ¡³öÓëµ÷¿ØÓÐЧ³É·Öº¬Á¿µÄ»ùÒò½ôÃÜÁ¬ËøµÄf¡£ [ Last edited by zhangxia on 2011-9-2 at 11:11 ] |
» ²ÂÄãϲ»¶
269Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
µç×ÓÐÅÏ¢270Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ר˶085403£¬291·Ö£¬ÓÐÁ½Æª×¨Àû£¬Ò»¹úÒ»½±
ÒѾÓÐ3È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
290Çóµ÷¼Á085701
ÒѾÓÐ16È˻ظ´
081200-11408-276ѧ˶Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸085404£¬×Ü·Ö291£¬Ëļ¶Òѹý£¬Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
zhangxia
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 655.3
- É¢½ð: 10
- ºì»¨: 1
- Ìû×Ó: 77
- ÔÚÏß: 75.3Сʱ
- ³æºÅ: 342879
- ×¢²á: 2007-04-10
- רҵ: huaxue
2Â¥2011-09-02 11:12:02
woai820
ľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 11
- Ó¦Öú: 85 (³õÖÐÉú)
- ½ð±Ò: 2550.6
- É¢½ð: 200
- ºì»¨: 3
- ɳ·¢: 2
- Ìû×Ó: 2218
- ÔÚÏß: 134.6Сʱ
- ³æºÅ: 1382317
- ×¢²á: 2011-08-28
- ÐÔ±ð: MM
- רҵ: µç»¯Ñ§
¡ï ¡ï
sltmac(½ð±Ò+2): ¸ÐлӦÖú~ 2011-09-02 18:40:43
zhangxia(½ð±Ò+10, ·ÒëEPI+1): xiexie 2011-09-05 17:21:09
°®ÓëÓêÏÂ(·ÒëEPI-1): ³·ÏúEPI 2011-09-07 08:34:30
sltmac(½ð±Ò+2): ¸ÐлӦÖú~ 2011-09-02 18:40:43
zhangxia(½ð±Ò+10, ·ÒëEPI+1): xiexie 2011-09-05 17:21:09
°®ÓëÓêÏÂ(·ÒëEPI-1): ³·ÏúEPI 2011-09-07 08:34:30
| This topic unifies a and the new member labeling technique, application different dosage b carries on the exposure mutagenesis to c, uses the d technology and e, to regulates its effective component content the gene type to carry on the analysis, screens and regulative effective component content gene close chain-like f. |

3Â¥2011-09-02 15:29:58
laozhuangzi
ͳæ (ÕýʽдÊÖ)
|
4Â¥2011-09-06 15:46:36
laozhuangzi
ͳæ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 35.8
- É¢½ð: 110
- ºì»¨: 5
- Ìû×Ó: 487
- ÔÚÏß: 69.9Сʱ
- ³æºÅ: 1376427
- ×¢²á: 2011-08-22
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯ¹¤ÓëʳƷ»¯¹¤
5Â¥2011-09-06 15:47:18














»Ø¸´´ËÂ¥